Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Working Capital Changes (2019 - 2025)

AVITA Medical's Other Working Capital Changes history spans 7 years, with the latest figure at -$189000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 79.96% year-over-year to -$189000.0; the TTM value through Dec 2025 reached -$1.3 million, down 52.31%, while the annual FY2025 figure was $141212.0, 70.97% down from the prior year.
  • Other Working Capital Changes reached -$189000.0 in Q4 2025 per RCEL's latest filing, down from $136729.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $479000.0 in Q2 2021 to a low of -$943000.0 in Q4 2024.
  • Average Other Working Capital Changes over 5 years is $32405.6, with a median of $64960.0 recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 7744.0% in 2023, then crashed 638.79% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$166000.0 in 2021, then surged by 74.7% to -$42000.0 in 2022, then soared by 647.62% to $230000.0 in 2023, then plummeted by 510.0% to -$943000.0 in 2024, then surged by 79.96% to -$189000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Other Working Capital Changes are -$189000.0 (Q4 2025), $136729.0 (Q3 2025), and $123395.0 (Q2 2025).